rss
Ann Rheum Dis 1999;58:691-697 doi:10.1136/ard.58.11.691
  • Extended report

Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis

  1. Yrjö T Konttinena,b,
  2. Mia Ainola,
  3. Heikki Vallealab,
  4. Jian Mab,
  5. Hideo Idac,
  6. Jami Mandelinb,
  7. Raimund W Kinned,
  8. Seppo Santavirtae,
  9. Timo Sorsaf,
  10. Carlos López-Otíng,
  11. Michiaki Takagic
  1. aDepartment of Oral Medicine, University of Helsinki, Finland, bDepartment of Medicine, Helsinki University Central Hospital and Department of Anatomy, University of Helsinki, Finland, cDepartment of Orthopaedic Surgery, Yamagata University School of Medicine, Yamagata, Japan, dExperimental Rheumatology, Friedrich-Schiller-University, Jena, Germany, eDepartment of Orthopaedics and Traumatology, Helsinki University Central Hospital, Helsinki, Finland, fDepartment of Periodontology, University of Helsinki, Finland, gUniversity of Oviedo, Oviedo, Spain
  1. Dr Y T Konttinen, Institute of Biomedicine, Department of Anatomy, PO Box 9 (Siltavuorenpenger 20 A), FIN-00014 University of Helsinki, Finland.
  • Accepted 19 June 1999

Abstract

OBJECTIVE To define the pattern of mRNA expression of all human matrix metalloproteinases (MMPs) described to date in rheumatoid arthritis (RA) and traumatic synovial membrane, in order to differentiate between a physiological tissue remodelling pattern and that associated with inflammatory tissue destruction.

METHODS Analysis of SwissProt protein and EMBL/GenBank nucleotide sequence banks, protein sequence alignment, reverse transcriptase-polymerase chain reaction and nucleotide sequencing were used.

RESULTS MMP-2 (gelatinase A), MMP-3 (stromelysin-1), MMP-11 (stromelysin-3) and MMP-19 were constitutively expressed. MMP-1 (fibroblast type collagenase), MMP-9 (gelatinase B) and MMP-14 (MT1-MMP) were expressed in all RA, but only in 55–80% of trauma samples. MMP-13 (collagenase-3) and MMP-15 (MT2-MMP) were expressed exclusively in RA (80–90% of the samples). MMP-20 (enamelysin) was absent and MMP-8 (collagenase-2) was rarely found in RA or trauma. All other MMPs (-7, -10, -12, -16, -17) had an intermediate pattern of expression.

CONCLUSIONS Some MMPs without interstitial collagenase activity seem to have a constitutive pattern of expression and probably participate in physiological synovial tissue remodelling. Some MMPs are exclusively associated to RA synovitis, for example, MMP-13, which preferentially degrades type II collagen and aggrecan, and MMP-15, which activates proMMP-2 and proMMP-13 and is involved in tumour necrosis factor α processing. This clear cut rheumatoid/inflammatory MMP profile, more complex than has been previously appreciated, may facilitate inflammatory tissue destruction in RA.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.